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Oliver et al. have conducted a survival analysis of >3000 patients using prospective data from the local database of a large adult congenital heart disease (ACHD) unit in Madrid (Spain). 1 The results were cross-checked with the Spanish National Death Index in order to calculate the standardized mortality ratio (SMR). There are two fascinating findings in the study of Oliver et al. First, there is a significant overlap in death rate across subgroups based on anatomical complexity of the underlying congenital heart defect; and, secondly, the authors were able to demonstrate that in the absence of additional risk factors, independent of the underlying anatomical complexity, ACHD survival did not differ from that of the reference population.
The annual death rate for the entire cohort was 0.89% and the SMR was 2.64 [95% confidence interval (CI) 2.3-3.0], which is very similar to a recent report from Diller et al. who reported an annual death rate of 0.72% and an SMR of 2.29 (95% CI 2.08-2.53) in their patient cohort. 2 Although SMRs increased with increasing complexity of the underlying congenital heart defect and annual death rate was higher in patients with complex congenital heart disease (2.04%), mortality rates did not differ between simple and moderate complex congenital heart defects (0.79% and 0.68%, respectively); this for a median follow-up time of 10.5 years and a median age at entry of 22.5 years.
The authors categorized patients based on the three different diagnostic categories of complexity, defined as outlined by Task Force 1 of the 32nd Bethesda Conference. 3 Although the initial idea of this classification may have been to decide which patients need to be followed at a tertiary care ACHD centre, increasing complexity has been related to adverse outcome in previous reports. As the current study clearly showed considerable overlap of death rates across subgroups, one can see that this classification-although helpful-is flawed in determining as the only parameter to evaluate who has the greatest risk, who is unstable or-in essence-who requires closer follow-up and treatment. Hence, categorization of ACHD just based on anatomical findings is insufficient to predict outcome. Similar discussions were held when the ESC Working Group on Grown-up Congenital Heart Disease and the Section of Sports Cardiology of the EACPR decided to write a current opinion paper on physical activity in ACHD. 4 Besides anatomical complexity, haemodynamic and electrophysiological factors may play an important role in risk assessment. These components, absent in the anatomical categorization, also explain why annual death rates and SMRs for the same (anatomical) defects will differ between different ACHD cohorts. Increasing SMRs with worsening functional class, independent from the underlying congenital heart defect, reinforce this idea.
2 Figure 1 summarizes standardized mortality ratio based on disease complexity, risk factors, and functional class. Secondly, the authors were able to demonstrate that in the absence of additional risk factors, independent of the anatomical complexity, ACHD survival did not differ from that of the reference population and is in line with what was discussed earlier. Oliver et al. identified 11 variables that were related to adverse outcome: genetic disorders, single ventricle physiology, clinical cyanosis, severe pulmonary outflow tract obstruction, subaortic and subpulmonic moderate to severe ventricular systolic dysfunction, significant subaortic atrioventricular valve regurgitation, severe pulmonary hypertension, infective endocarditis, aortic aneurysm, and ischaemic heart disease. Although Kaplan-Meier curves are redundantly used to illustrate early and late outcome of specific patient groups, they lack the detail to provide information about individual risk. The variables identified by Oliver et al. are a useful attempt at individualizing risk assessment in daily clinical ACHD practice. Further epidemiological data could refine our risk assessment models in order to provide accurate individualized patient risk stratification. [5] [6] [7] [8] Inclusion of biomarkers, haemodynamic data, and electrophysiological parameters is needed to tailor treatment and follow-up within or across anatomical defects. These models work well within the population studied, but cannot be extrapolated for a large-scale integration. Knowledge of different ACHD populations and their local risk leads to more precise risk assessment, which is in line with the SCORE project that estimated the 10-year risk of fatal cardiovascular disease from a pooled data set obtained from 12 European cohort studies. 9 The risk factors identified by Oliver et al. are valuable in daily practice as our ACHD patients often have questions with regards to their short-, medium-, and longterm outcome. The information is crucial to motivate lifestyle changes, for vocational purposes, and for family planning. Survival patterns just based on complexity of the underlying anatomical pathology are too rough and again underscore the need for a more individualized risk assessment. Unfortunately, nowadays, private insurance companies, when seeking information with regards to insurability of the patient, frequently rely on crude survival curves instead of balancing the individual risk. This results in insurance requests that are erroneously refused, with the well-being and quality-of-life of ACHD patients being negatively affected. The community of ACHD caregivers has an obligation to follow up on evolving scientific data, and to interpret findings correctly and translate them into daily practice. Obviously, risk factors may change over time (time-dependent variables), underlining the need for systematic re-assessment during follow-up. This information could be useful to determine follow-up times on a more scientific basis when the ESC guidelines for the management of grown-up congenital heart disease 10 will be revised.
Finally, Oliver et al. chose overall mortality as a primary endpoint in their analysis. It is often debated whether cardiac or cardiovascular mortality would be preferable as a primary endpoint. From the patients' perspective, the patient is perhaps best served with information on all-cause mortality (it is also considered as the hardest endpoint in clinical studies). However, when the scientific ACHD community would be interested in modifiable variables of outcome, a more in-depth analysis of causes of death would be required. Remarkably, Diller et al. demonstrated a relatively high proportion of patients dying from non-cardiac causes. 2 The leading cause of death was chronic heart failure (42%), followed by pneumonia (10%), sudden cardiac death (7%), cancer (6%), and haemorrhage (5%). Raissadati et al. found similar results in patients who underwent congenital cardiac surgery and were followed into adulthood. They showed that deaths from neoplasms, respiratory, neurological, and infectious disease were significantly more common among study patients than controls. Pneumonia caused the majority of non-chronic heart disease-related deaths among the study population. 11 Both studies suggest that cardiac-related death decreased with increasing patient age, whereas the number of patients dying from non-cardiac causes increased. Moreover, the most important cardiac cause of death in ACHD patients was heart failure. Those findings suggest that our focus in the management of ACHD patients would be to optimize treatment of heart failure, 12 but not to lose track of non-cardiac causes of death if we want to improve the outcomes of our patients further. In summary, Oliver et al. have written an original paper by identifying predictors of outcome that exceed categorization based on the underlying anatomical complexity. In the absence of those risk factors, survival is similar to that of a reference population. Their data indicate that-apart from the underlying anatomy-haemodynamic and electrophysiological factors as well as non-cardiac co-morbidities are important and could result in more individualized risk assessment. 
